The US Natrecor [nesiritide] label has been revised by Johnson & Johnson to include data on mortality risk

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1052, 2005-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carbamazepine, HLA-B*1502 and risk of Stevens––Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations

By Ferrell P Brent   McLeod Howard L  

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1543-1546

Future Medicine

Access to resources Recommend Favorite

A unique form of infant leukaemia has been identified by US-based researchers.

By  

Inpharma, Vol. 1, Iss. 1318, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Estradiol gel [EstroGel; Solvay] has been launched in the US

By  

Inpharma, Vol. 1, Iss. 1450, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

A broad label extension has been approved by the European Commission for bevacizumab [Avastin; Roche].

By  

Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Pooled analysis shows increased mortality with nesiritide

By  

Reactions Weekly, Vol. 1, Iss. 1049, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite